You are managing a clinical trial with an upcoming interim analysis deadline, a new patient experiencing an unexpected adverse event requiring immediate attention, and a critical site audit scheduled for next week. How would you prioritize these tasks, and what steps would you take to address each effectively while ensuring patient safety and data integrity?

Prioritize using the MECE framework: Mutually Exclusive (tasks are distinct), Collectively Exhaustive (all tasks covered). First, address the adverse event (AE) immediately: ensure patient safety, document thoroughly, notify PI/sponsor per protocol. Second, prepare for the critical site audit: review essential documents, source data, regulatory binders, and address any identified gaps. Third, manage the interim analysis: delegate data entry/cleaning, review statistical analysis plan, and ensure data integrity for submission. This ensures patient safety is paramount, compliance is maintained, and study timelines are met effectively.

I would prioritize these tasks using the RICE framework: Reach, Impact, Confidence, Effort. Patient safety is paramount, so the unexpected adverse event takes immediate priority. I would ensure the patient receives appropriate medical attention, document the event thoroughly, and notify the Principal Investigator and sponsor per protocol. This is high impact and high confidence. Next, I would focus on the critical site audit. This has high impact on study integrity and compliance. I'd review all essential documents, source data, and regulatory binders, addressing any discrepancies proactively. Finally, I would manage the interim analysis deadline. While critical, some aspects can be delegated. I would ensure data entry is complete, perform a final data quality check, and collaborate with the biostatistician to ensure timely and accurate submission, maintaining data integrity throughout. This structured approach ensures patient well-being, regulatory compliance, and study progress.